APA (7th ed.) Citation

Ning, Y., Huang, L., Wang, Q., Liu, L., Ni, X., Xie, X., . . . Gao, H. Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways. BMC.

Chicago Style (17th ed.) Citation

Ning, Yujie, et al. Hederasaponin C Ameliorates Chronic Obstructive Pulmonary Disease Pathogenesis by Targeting TLR4 to Inhibit NF-κB/MAPK Signaling Pathways. BMC.

MLA (9th ed.) Citation

Ning, Yujie, et al. Hederasaponin C Ameliorates Chronic Obstructive Pulmonary Disease Pathogenesis by Targeting TLR4 to Inhibit NF-κB/MAPK Signaling Pathways. BMC.

Warning: These citations may not always be 100% accurate.